Buy, Sell or Hold: Merck KGAA (MKGAY-GR)

Merck KGAA (MKGAY-GR)

0.00

0.00 (0.00%) 1d

PAST TOP PICK

(Top Pick Nov 23/10, Up 13.49%) They produce cancer drugs. They produce LCD crystals. Interesting company. Descent pipeline on the pharma side.

TOP PICK

(German Exchange. Sister company to US Merck.) 75% Pharmaceuticals plus a lab sector and an LCD (liquid crystals) sector.

Showing 1 to 2 of 2 entries

Merck KGAA(MKGAY-GR) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Merck KGAA is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Merck KGAA(MKGAY-GR) Frequently Asked Questions

What is Merck KGAA stock symbol?

Merck KGAA is a OTC stock, trading under the symbol MKGAY-GR on the (). It is usually referred to as or MKGAY-GR

Is Merck KGAA a buy or a sell?

In the last year, there was no coverage of Merck KGAA published on Stockchase.

Is Merck KGAA a good investment or a top pick?

Merck KGAA was recommended as a Top Pick by on . Read the latest stock experts ratings for Merck KGAA.

Why is Merck KGAA stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Merck KGAA worth watching?

In the last year 0 stock analysts on Stockchase covered Merck KGAA. The stock is worth watching.

What is Merck KGAA stock price?

On , Merck KGAA (MKGAY-GR) stock closed at a price of $.

Most Recent Experts

Greg Newman

Scotia Wealth Management

Stockchase Insights

5i Research

Shane Obata

Middlefield Capital

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Andrew Pyle

The Pyle Group, Scotia Wealth Mgt.

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.